I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Matthew F Reeves
Expertise: Family Planning, Gynecology, Women's Reproductive Health
Matthew Reeves, MD, MPH, attended Harvard Medical School and completed residency in obstetrics & gynecology at the University of California, San Francisco (UCSF). He then completed a fellowship in Clinical Ultrasound at the UCSF Department of Radiology followed by the Fellowship in Family Planning & Contraceptive Research at the University of Pittsburgh. In addition to his clinical work at Sibley Memorial Hospital, Dr. Reeves also serves as Medical Director at the National Abortion Federation, Associate Director for Research at the Fellowship in Family Planning at Washington Hospital Center, and Adjunct Clinical Associate Professor of Obstetrics & Gynecology at Stanford University School of Medicine.
Dr. Reeves has conducted research on applications of ultrasound, contraceptive development, cost-effectiveness, early phase clinical trials of HIV-prevention products, and provision of reproductive health services globally. Previously, Dr. Reeves was the Chief Medical Officer for WomenCare Global. Prior to moving to Washington, DC, he was on faculty at the University of Pittsburgh School of Medicine and an attending physician at Magee-Womens Hospital working in both the Ultrasound and Gynecologic Specialties divisions.
Research & Publications
Selected PublicationsView all on Pubmed
Casey FE, Ye PP, Perritt JD, Moreno-Ruiz NL, Reeves MF. Same-Day Mifepristone and Misoprostol Compared to Misoprostol only for Cervical Preparation prior to Second-Trimester Surgical Abortion. Contraception. [accepted; epub 4 March 2016; PMID 26948184.
Reeves MF, Zhao Q, Secura GM, Peipert JF. Risk of unintended pregnancy based on intended compared to actual contraceptive use. American Journal of Obstetrics and Gynecology. 215(1): 71.e1-6, 2016 July. PMID 26805610
Reeves MF, Monmaney JA, Creinin MD. Predictors of Uterine Evacuation following Early Medical Abortion with Mifepristone and Misoprostol. Contraception. 93(2): 119-25, 2015 February. PMID 26285178.
Bednarek PH, Creinin MD, Reeves MF, Cwiak CA, Espey E, Jensen JT. Immediate Versus Delayed Intrauterine Device Insertion Following Uterine Aspiration between 5 and 12 Weeks Gestation: A Randomized Controlled Trial. New England Journal of Medicine. 364(23): 2212-21, 2011 June 9. PMID 21651392.
Activities & Honors
- Diplomate, American Board of Obstetrics & Gynecology, 2008
- Fellow, American College of Obstetricians & Gynecologists
- Fellow, Society of Family Planning